Semaglutide, GLP-1 Medications, and Hair Loss: What to Track

Hair loss on a GLP-1 medication like semaglutide (Ozempic, Wegovy) or tirzepatide is reported by a minority of users, and the evidence points to it being telogen effluvium - a temporary, diffuse shedding usually triggered by rapid weight loss rather than a direct drug toxicity to the follicle. In the Wegovy trials, hair loss was reported in about 2.5% of people on semaglutide versus 1.0% on placebo. The follicles are not destroyed, so regrowth is the usual outcome once weight stabilizes and any nutritional gaps are addressed. Because the shedding is delayed and diffuse, the most useful thing you can do is track the timeline, your rate of weight loss, and your overall scalp density so you can tell a self-limiting shed from something that needs a clinician.

Does semaglutide cause hair loss?

Hair loss is a recognized but uncommon adverse event in the weight-management trials of semaglutide. The FDA prescribing information for Wegovy (semaglutide 2.4 mg) lists alopecia as occurring in about 2.5% of treated adults compared with 1.0% on placebo. Other GLP-1 receptor agonists, including tirzepatide, have shown a similar pattern in trial and pharmacovigilance data. So the honest framing is: most people do not lose hair on these drugs, a minority do, and when it happens it has the hallmarks of a temporary shed rather than permanent loss.

It also matters that the diabetes-dose trials (lower doses, less dramatic weight loss) reported hair loss less often than the higher-dose weight-loss trials. That dose-to-weight-loss relationship is one of the main reasons researchers suspect the shedding is driven by the speed and size of weight loss rather than a direct follicle effect of the drug.

Why does it happen? Telogen effluvium and rapid weight loss

The leading explanation is telogen effluvium. Normally most of your hair is in the active growth (anagen) phase and only a fraction is resting (telogen). A physical stressor - rapid weight loss, a sharp drop in calorie intake, a sudden change in metabolism - can push an unusually large share of follicles into the resting phase at once. Those hairs are then shed together a couple of months later, which is why the shedding feels sudden and diffuse rather than patchy. The same mechanism explains shedding after crash diets, bariatric surgery, childbirth, and serious illness.

Rapid weight loss can also create or unmask nutritional gaps. Eating much less, and feeling much less hungry, can lower intake of protein, iron, zinc, and other nutrients the hair cycle depends on. None of this means the medication is “poisoning” your follicles; it means the body is reacting to a large, fast change. Telogen effluvium does not scar the follicle, so the capacity to regrow remains.

How long does GLP-1 hair loss last?

Telogen effluvium usually begins 2 to 4 months after the trigger and runs for several months. Once the trigger settles - in this case weight loss slows and your intake stabilizes - new hairs typically start replacing the shed ones, though it can take many months for density to visibly recover. The shedding being delayed is exactly why people often blame the wrong week: the hair you are losing now reflects a stressor from two to three months ago. A dated log is far more useful here than memory.

What should you track on a GLP-1 medication?

• Onset date: note when increased shedding started, and count back 2 to 3 months to find the likely trigger window (a dose increase, a sharp drop in intake, an illness).
• Rate of weight loss: log weight regularly. Very fast loss is the variable most linked to telogen effluvium, and it is something you and your clinician can adjust.
• Nutrition markers: ask your clinician whether protein intake and labs such as ferritin, vitamin D, and zinc are worth checking. Do not self-diagnose deficiencies from a blog.
• Diffuse density photos: capture the part line, the top of the scalp, and the crown in the same room, light, distance, and camera, so you can see whether overall density is recovering.
• The hair pull pattern: heavy, even shedding across the whole scalp fits telogen effluvium; patchy bald spots, scaling, or scarring do not and warrant a clinician.

Will my hair grow back if I stay on the medication?

For most people whose shedding is telogen effluvium driven by weight loss, density recovers as the weight-loss curve flattens and intake stabilizes, even while staying on treatment, because the follicles were never permanently damaged. That is a general pattern, not a promise for any individual, and it is exactly the kind of trajectory a consistent photo log makes visible. If you also carry a genetic pattern loss, the stress shed can unmask thinning that was already underway, which is one more reason to track and to talk to a clinician rather than guess.

Common questions

Is GLP-1 hair loss permanent?

The reported pattern is telogen effluvium, which is reversible because the follicles are not scarred. Regrowth is the usual outcome once the trigger settles, though it is gradual. Permanent loss would look different (patchy, scarred, or following a clear genetic pattern) and should be assessed by a clinician.

Should I take a hair supplement while on Ozempic or Wegovy?

Supplements only help if you are actually low in something, and high doses of some nutrients can cause their own problems. The better move is to ask your clinician whether your protein intake and labs are adequate during rapid weight loss, rather than stacking pills based on marketing. This is not dosing advice; it is a reason to bring the question to the person managing your treatment.

Does losing weight more slowly reduce the shedding?

Because the shedding tracks with the speed and size of weight loss rather than the drug itself, pacing the loss is a plausible lever, and it is one your prescriber can help you manage. Your weight-and-shedding log is what makes that conversation concrete instead of guesswork.

Sources: FDA - Wegovy (semaglutide) prescribing information (adverse reactions, including alopecia), American Academy of Dermatology - telogen effluvium, and Branyiczky et al. 2025 - Effects of GLP-1 receptor agonists on hair loss and regrowth: a systematic review (Int J Dermatol).